JESSICA OKEY: Open Payments
NPI 1902573959 · HILLIARD, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,563 in 126 payments from 18 companies in 2025. Trend: 2023 $2,691 · 2024 $2,572 · 2025 $2,563
Food & beverage: $2,563
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 42 | $827 |
| Janssen Biotech, Inc. | 22 | $387 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $377 |
| QOL Medical, LLC | 7 | $197 |
| Madrigal Pharmaceuticals | 7 | $152 |
| Phathom Pharmaceuticals, Inc. | 4 | $80 |
| Lilly USA, LLC | 4 | $76 |
| Gilead Sciences, Inc. | 4 | $74 |
| GENZYME CORPORATION | 3 | $60 |
| Regeneron Healthcare Solutions, Inc. | 2 | $60 |
Products named: TREMFYA, ENTYVIO, RINVOQ, Sucraid, SKYRIZI, CREON, REZDIFFRA, DUPIXENT.
Industry payments across OH — which companies pay providers there.
